Affects 25 million adults in the US

GLP-1 Weight Loss for Sleep Apnea

Obstructive sleep apnea (OSA) affects approximately 25 million adults in the United States, and excess body weight is the single greatest risk factor -- roughly 70% of people with OSA are overweight or obese. The condition causes repeated interruptions in breathing during sleep, leading to poor sleep quality, daytime fatigue, elevated blood pressure, and increased cardiovascular risk. Sleep apnea and weight gain feed each other: poor sleep disrupts hunger hormones (ghrelin and leptin), increasing appetite and cravings, which drives further weight gain and worsens the sleep apnea.

Clinically proven GLP-1 treatment for Sleep Apnea. Prescribed by licensed providers, delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Sleep Apnea is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated March 2026Medically reviewed by licensed providers

GLP-1 medications (semaglutide and tirzepatide) are clinically proven weight loss treatments for patients with Sleep Apnea. It affects approximately Affects 25 million adults in the US of U.S. adults. Weight Method offers treatment starting at $297/month with virtual consultations and direct shipping.

How do GLP-1 medications help with this condition?

GLP-1 receptor agonists break the sleep-apnea-weight-gain cycle by producing significant, sustained weight loss. The landmark SURMOUNT-OSA trial demonstrated that tirzepatide reduced apnea-hypopnea index (AHI) events by up to 63% in patients with moderate-to-severe OSA. Semaglutide has shown similar benefits, with many patients reducing or eliminating their need for CPAP therapy after meaningful weight loss. By reducing fat deposits around the neck and airway, GLP-1 medications directly address the mechanical cause of obstructive sleep apnea.

Who qualifies for treatment?

Patients with diagnosed or suspected sleep apnea and a BMI of 27 or higher are strong candidates for GLP-1 treatment. If you've been prescribed a CPAP machine but struggle with compliance, weight loss through GLP-1 therapy may reduce or eliminate your need for the device. Weight Method's assessment considers sleep apnea as a significant comorbidity when evaluating eligibility.

Ready to Get Started?

Answer a few quick questions to see if you qualify for GLP-1 medication.

Check Eligibility

How It Works

1

Take the Quiz

Answer questions about your health and medical condition.

2

Virtual Consultation

A provider will review your case and create a personalized plan.

3

Get Your Medication

Your GLP-1 medication ships directly to your door.

Your Treatment Options

Clinically proven GLP-1 medications at transparent prices

Starting at$297/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Same active ingredient as Ozempic® & Wegovy®. Proven to reduce body weight by up to 15%.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Same active ingredient as Mounjaro® & Zepbound®. Dual-action GLP-1/GIP for enhanced results.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Studies show that even a 10% reduction in body weight can reduce AHI events by 50% or more. With GLP-1 medications, most patients achieve this level of weight loss within 6-9 months, leading to measurable improvements in sleep quality and oxygen levels.

Many patients are able to reduce CPAP pressure settings or discontinue CPAP entirely after significant weight loss. However, this decision should be made with your sleep medicine provider based on a follow-up sleep study confirming improvement.

Yes. Improved sleep quality normalizes hunger hormones and reduces cortisol levels, making it easier to maintain healthy eating habits. This creates a positive feedback loop where weight loss improves sleep, and better sleep supports further weight loss.

The SURMOUNT-OSA trial specifically studied tirzepatide and showed impressive results for sleep apnea. Semaglutide is also effective through general weight loss benefits. Your Weight Method provider can discuss which option may produce the best outcomes for your situation.

Some patients report improved sleep within the first few months as initial weight loss begins. However, significant reductions in AHI events typically occur after 10-15% body weight loss, which most patients achieve within 6-12 months of treatment.

Start Your Treatment

Find out if GLP-1 medications can help you lose weight with Sleep Apnea.

Get Started Now

Free consultation. No commitment.

GLP-1 Medications

SemaglutideTirzepatideSemaglutide vs Tirzepatide

Other Conditions

PCOSType 2 DiabetesHypothyroidismHigh Blood PressureJoint Pain & ArthritisMetabolic SyndromePrediabetes

Sleep Apnea by City

Sleep Apnea in Abbeville, LASleep Apnea in Aberdeen, MDSleep Apnea in Aberdeen, SDSleep Apnea in Aberdeen, WASleep Apnea in Abilene, TXSleep Apnea in Acworth, GASleep Apnea in Ada, OKSleep Apnea in Addison, IL